The ARP Nominations & Appointments Committee plays a pivotal role in overseeing the nominations process, ensuring the election and appointment of qualified leaders and volunteers who reflect the diverse membership of ARP. Together with the ACR’s Marketing & Communications Department, we kick off the 2025 term by promoting the annual Call for Volunteers and identifying…
When speaking to ACR and ARP members, people are always interested in hearing about the most recent news coming out of the ACR, specifically in areas of interest to them and their patients. It was these discussions that prompted me to make enhancing connections and communications between the ACR and its members one of my…
In visits to Congress members and staff, more than 120 ACR/ARP members and patients urged action to improve patient access to quality treatment. The meetings included discussions about the importance of research funding, ensuring adequate Medicare reimbursement, protecting Medicaid, and making PBMs more transparent and accountable. It’s not too late to amplify their message.
The rescindment of the Richardson Waiver in late February suggests that the HHS may move toward rulemaking without providing public notice and comment procedures.
The nominations of Jay Bhattacharya, MD, PhD, as director of the National Institutes of Health and Martin Makary, MD, MPH, for commissioner of the Food & Drug Administration have the potential to significantly impact federally funded healthcare research, federal responses to public health emergencies and federal regulation of drugs and medical devices.
This annual event, to be held May 4–6, brings together the rheumatology community to advocate on Capitol Hill for the profession and rheumatic disease patients.
The proposed changes aim to address modern breach and cybersecurity risks to electronic protected health information and common deficiencies observed by the HHS in Security Rule compliance investigations.
The Medicare Patient Access and Practice Stabilization Act of 2025 would fully offset the harmful 2.8% cut in the MPFS and include an additional 2% payment update to physician services furnished after April 1.
As state legislatures begin to convene their sessions in 2025, several key issues related to rheumatology are expected to take center stage, including drug costs, utilization management, telehealth and copay accumulators.
ACR President Carol A. Langford, MD, MPH, highlights the importance of research in the field and where to find resources and initiatives within the ACR to support, fund, inspire, and enhance innovation. For more on this important topic, see Dr. Langford’s column in the January issue of The Rheumatologist.